NCT01369589 - An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

XerostomiaSjogren's Syndrome

Interventions

DRUG

P-552

P-552 will be administered as 10 mL mouth rinse to be swished in the mouth fro 30 seconds and then completely expectorated.

DRUG

Placebo

Placebo will be administered as 10 mL mouth rinse to be swished in the mouth for 30 seconds and then completely expectorated.

Trial Locations (1)

Tufts University School of Dental Medicine, Boston